MK-8242

News alerts, weekly reports and conference planners

Company:

Merck (MSD)

Drug class:

MDM2 inhibitor

Related drugs:

TP53 wild-type	Liposarcoma	TP53 wild-type	Liposarcoma	MK-8242 Sensitive: C3 – Early Trials MK-8242 Sensitive : C3	MK-8242 Sensitive: C3 – Early Trials MK-8242 Sensitive : C3
TP53 wild-type	Solid Tumor	TP53 wild-type	Solid Tumor	MK-8242 Sensitive: C3 – Early Trials MK-8242 Sensitive : C3	MK-8242 Sensitive: C3 – Early Trials MK-8242 Sensitive : C3

Associations
(2)